Volume 20 - Issue 7 - July 2007
Wound Care Q&A »
Given the increasing use of negative pressure wound therapy (NPWT) to spur wound healing, our expert panelists return for the second part of this Q&A discussion on NPWT (see “Inside Insights On Negative Pressure Wound Therapy,” page 24, May issue). They offer specific pearls on the use of NPWT, how to combine the modality with skin grafts and silver dressings, and tips for avoiding wound maceration.
Q: Do you have any pearls for using negative pressure wound therapy (NPWT)?
A: Eric Travis, DPM, utilizes VAC therapy (KCI) mostly at 125 mmHg of continuous suction. For a fragile w
Given the severe ramifications associated with the combination of critical limb ischemia (CLI) and diabetic foot ulcers, this author emphasizes the potential impact of revascularization procedures in reducing the number of lower extremity ampulations. Accordingly, he offers a closer looks at recent advances in this arena and their place within the armentarium for CLI
It has been estimated that a person with diabetes has a 25 percent lifetime risk of developing a foot ulceration.1 Diabetic foot ulcers commonly become infected, can involve bones and joints and may progress to amputation. Osteomyelitis frequently complicates ulcerations in people with diabetes and may be present in up to 20 percent of mild to moderate and 50 to 60 percent of severely infected wounds.2
Continuing Education » MRSA
Given the increasing prevalence of methicillin resistant Staphylococcus aureus (MRSA), these authors discuss the differences between HA-MRSA and CA-MRSA, what the literature reveals about antibiotic therapy and keys to the diagnostic workup of these patients.
- « Previous
- | Page 1 of 3 |
- Next »